Literature DB >> 15809792

Laparoscopic esophagectomy in the palliative treatment of advanced esophageal cancer after radiochemotherapy.

A Del Genio1, G Rossetti, V Napolitano, V Maffettone, A Renzi, L Brusciano, G Russo, G Del Genio.   

Abstract

BACKGROUND: Esophageal cancer is associated with a poor long-term prognosis. Only a 10% 5-year survival rate is reported. This article aims to evaluate the feasibility and efficacy of laparoscopic esophagectomy for the palliative treatment of advanced esophageal cancer (T3-T4 Nx-N1) after neoadjuvant therapy.
METHODS: From March 1998 to July 2002, 35 patients (mean age, 64.6 years; range, 35-72 years) affected by advanced cancer of the middle lower third of the esophagus came to the authors' observation. All received neoadjuvant radiochemotherapy. Of the 35 patients, 22 (62.9%) showed a positive response to treatment (>or=50% reduction of maximal cross-sectional area of the tumor), and surgical intervention was performed 4 weeks after the end of the therapy. The operations were accomplished through the laparoscopic approach and left lateral cervicotomy.
RESULTS: The mean operative time was 160 min (range, 120-260 min). One patient (4.5%) experienced a cervical anastomotic leak. Three patients (13.6%) died in the postoperative period: one of myocardial infarction and two of acute respiratory failure. The mean postoperative hospital stay was 12.1 days (range, 9-23 days). After a mean follow-up period of 20.2 months (range, 10-40 months), 13 patients (68.4%) were alive.
CONCLUSIONS: The laparoscopic approach seems to be effective for the palliative treatment of advanced esophageal cancer. Further trials will be necessary to evaluate the advantages of this technique.

Entities:  

Mesh:

Year:  2004        PMID: 15809792     DOI: 10.1007/s00464-003-9243-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  50 in total

1.  Cancer of the esophagus. The Cleveland Clinic experience.

Authors:  S Galandiuk; R E Hermann; D M Cosgrove; J J Gassman
Journal:  Ann Surg       Date:  1986-01       Impact factor: 12.969

2.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

3.  Three-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age.

Authors:  W Fang; H Igaki; Y Tachimori; H Sato; H Daiko; H Kato
Journal:  Ann Thorac Surg       Date:  2001-09       Impact factor: 4.330

4.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

Review 5.  Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference?

Authors:  R Rindani; C J Martin; M R Cox
Journal:  Aust N Z J Surg       Date:  1999-03

6.  Minimally invasive esophagectomy.

Authors:  J D Luketich; P R Schauer; N A Christie; T L Weigel; S Raja; H C Fernando; R J Keenan; N T Nguyen
Journal:  Ann Thorac Surg       Date:  2000-09       Impact factor: 4.330

7.  Transthoracic esophagectomy: a safe approach to carcinoma of the esophagus.

Authors:  D J Mathisen; H C Grillo; E W Wilkins; A C Moncure; A D Hilgenberg
Journal:  Ann Thorac Surg       Date:  1988-02       Impact factor: 4.330

Review 8.  Can the morbidity of esophagectomy be reduced by the thoracoscopic approach?

Authors:  D Gossot; P Cattan; S Fritsch; B Halimi; E Sarfati; M Celerier
Journal:  Surg Endosc       Date:  1995-10       Impact factor: 4.584

9.  Transhiatal esophagectomy for benign and malignant disease.

Authors:  M B Orringer; B Marshall; M C Stirling
Journal:  J Thorac Cardiovasc Surg       Date:  1993-02       Impact factor: 5.209

10.  Transhiatal esophagectomy for carcinoma of the esophagus and cardia. Experience with 160 cases.

Authors:  G A Gelfand; R J Finley; B Nelems; R Inculet; K G Evans; G Fradet
Journal:  Arch Surg       Date:  1992-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.